Agilent Technologies (A - Free Report) has entered into a definitive agreement to acquire assets from Young In Scientific (YI Scientific), a South Korean company which distributes analytical instruments, solutions and services.
Further, YI Scientific has been the distributor of Agilent’s products and services in South Korea. Following the acquisition, its customers for Agilent’s products will have direct sales from Agilent. Consequently, the company’s customer base will improve which will help in revenue generation.
Moreover, Agilent’s buyout of Yi Scientific’s assets will aid Agilent cater to growing demand of analytical instruments In South Korea. Further, this will aid Agilent in strengthening its footprint in the international market.
Strategic Acquisitions — Key Catalyst
Over the past few years, strategic acquisitions have helped Agilent in paving its growth trajectory by expanding product portfolio and building customer base.
Recently, the company completed the acquisition of Switzerland-based Genohm, which provides cloud-based solutions to digitize its customers’ lab workflow. This will expand Agilent’s software portfolio by adding LIMS and workflow management.
Last month, the company also agreed to acquire the remaining 52% stake in a privately-held company, Lasergen, Inc., which focuses on the development of innovative technologies for DNA sequencing. The buyout will enable the company to strengthen its presence in the molecular diagnostics market.
In March, Agilent signed a definitive agreement to acquire Advanced Analytical Technologies. The deal will reinforce Agilent’s capillary electrophoresis solutions portfolio.
At the very beginning of 2018, the company announced the acquisition of Luxcel Biosciences which will fortify its presence in the high-growth cell analysis market. Further, the deal complements Agilent’s own product expansion efforts with the addition of assay kits.
Apart from these recent acquisitions, there are buyouts of Multiplicom NV (January 2017), Cobalt Light Systems (July 2017), Seahorse Bioscience and iLab Solutions (2016). These buyouts have also aided the expansion of Agilent’s product portfolio.
Consequently, we remain optimistic about Agilent's broad-based portfolio and increased focus on improving its product offerings.
Zacks Rank & Other Stocks to Consider
Currently, Agilent carries a Zacks Ranks #3 (Hold).
Some better-ranked stocks that can be considered in the broader technology sector are Littelfuse (LFUS - Free Report) , Stoneridge (SRI - Free Report) and AMETEK (AME - Free Report) . While Littelfuse and Stoneridge sport a Zacks Rank #1 (Strong Buy), AMETEK carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Long-term earnings growth rate for Littelfuse, Stoneridge and AMETEK is currently pegged at 12%, 8.5% and 10%, respectively.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>